"The risks of trial participation for an individual are logically measured against what an individual’s care trajectory would have been had they pursued care outside of a trial. Randomization potentially abrogates that care trajectory."
#Bioethics News: The gene drive - a new genetic engineering technology - could help us improve our environment and our lives, but it could also permanently alter the genetics of an entire species https://t.co/DAIiqL5Yri
"What are the attitudes of prospective patient-subjects? Do their preferences differ based upon the type of finding, such as whether it relates to prevention of a future health risk versus treatment of an existing condition?"
Qs and A's from Morain et al https://t.co/o9BDj4MgK5